Skip to main content
HUBC
NASDAQ Technology

Hub Cyber Security Pays $15.2M in Stock for Evofem Purchase Rights, Hires Advisor, and Drops Ferrox Deal

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Software Stocks · Technology
Sentiment info
Neutral
Importance info
8
Price
$1.03
Mkt Cap
$3.463M
52W Low
$0.95
52W High
$58,650
52W Position info
8.4% above low
Off High info
100% below high
Rel. Volume info
0.1× avg
Market data snapshot near publication time

HUBC is trading near its 52-week low of $0.95 (8.4% above the low) on light trading volume (0.1× avg).

Summary

Hub Cyber Security issued $15.2 million in stock to buy Evofem purchase rights, hired an advisor for a potential Evofem merger, and terminated the Ferrox acquisition.


Key Events · M&A and Partnerships · HUBC

  • Evofem Purchase Rights Acquired

    For $4 million face value of Evofem purchase rights, exercisable for 259.74 million Evofem shares at $0.0154 each, Hub Cyber Security paid $15.2 million in 10,133,333 ordinary shares and pre-funded warrants at $1.50 per share.

  • Financial Advisor Engaged

    PR Capital Limited Co. was hired as non-exclusive financial advisor for a potential Evofem business combination, receiving 2,627,118 shares and pre-funded warrants, with 2,101,694 shares subject to forfeiture if no deal closes.

  • Ferrox Acquisition Terminated

    Discussions for the acquisition of Ferrox Critical Minerals and its Tivani minerals project in South Africa were mutually ended by the company and Ferrox.

  • Shareholder Vote Required

    A shareholder meeting must be held to approve the exercise of pre-funded warrants and an increase in authorized share capital to accommodate the full issuance.


Analysis · HUBC · Technology

Deepening its commitment to the women's health sector, Hub Cyber Security is paying $15.2 million in its own shares and pre-funded warrants to acquire $4 million face value of Evofem Biosciences purchase rights. The deal is priced at $1.50 per HUBC share, a premium to the current $1.03 market price, but the issuance of 10.1 million shares (plus 2.6 million advisor shares) represents significant dilution for a micro-cap company with a going concern warning. To align incentives for a potential full business combination with Evofem, the company engaged PR Capital with restricted shares. Separately, it walked away from the Ferrox Critical Minerals acquisition, narrowing its strategic focus.

At the time of this filing, HUBC was trading at $1.03 on NASDAQ in the Technology sector, with a market capitalization of approximately $3.5M. The 52-week trading range was $0.95 to $58,650.00. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

HUBC - Latest Insights

HUBC
Aug 03, 2026, 7:31 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
HUBC
Jul 17, 2026, 5:00 PM EDT
Filing Type: 20-F
Importance Score:
9
HUBC
Jul 01, 2026, 8:40 AM EDT
Filing Type: 6-K
Importance Score:
9
HUBC
Jul 01, 2026, 7:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
HUBC
Jun 05, 2026, 10:43 AM EDT
Filing Type: 4
Importance Score:
7